The drugstore chain said sales rose 0.7 percent to $34.6 billion, primarily driven by improved retail sales and growth in the number of prescriptions filled in the U.S. in the most-recent quarter.
For the third quarter ended May 31, Walgreen’s reported net income of $1.03 billion, down 12.1 percent from the $1.34 billion the same period a year earlier.
The drop in profit was attributed to lower pharmacy margins and weakness in the U.K. drugstore business.
But Walgreens did beat analysts’ estimates in the third quarter.
“After what was a very disappointing second quarter for us, it is pleasing to be able to report that this quarter has been brought in line with our expectations,” Walgreens CEO Stefano Pessina said on a call with analysts, according to CNBC. “That said, the pressures we have seen for some time continue to impact our businesses, and we still have a lot to do to develop the transformation and data to get ahead of the market trends again and return our company to strong and consistent growth.”
More articles on pharmacy:
Walmart cutting some pharmacy jobs
UPMC acquires community pharmacy in Pittsburgh
Oklahoma judge approves Teva’s $85M opioid settlement
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
